AQR Capital Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.37M | Sell |
459,881
-60,007
| -12% | -$1.09M | 0.01% | 1043 |
|
|
2025
Q1 | $10.3M | Sell |
519,888
-10,280
| -2% | -$204K | 0.01% | 863 |
|
|
2024
Q4 | $9.09M | Sell |
530,168
-59,145
| -10% | -$1.01M | 0.01% | 853 |
|
|
2024
Q3 | $11.8M | Sell |
589,313
-184,093
| -24% | -$3.68M | 0.02% | 759 |
|
|
2024
Q2 | $8.65M | Sell |
773,406
-43,547
| -5% | -$487K | 0.01% | 805 |
|
|
2024
Q1 | $5.39M | Buy |
816,953
+225,750
| +38% | +$1.49M | 0.01% | 953 |
|
|
2023
Q4 | $2.67M | Buy |
591,203
+49,160
| +9% | +$222K | 0.01% | 1220 |
|
|
2023
Q3 | $1.94M | Buy |
542,043
+90,236
| +20% | +$323K | ﹤0.01% | 1338 |
|
|
2023
Q2 | $1.67M | Buy |
451,807
+312,493
| +224% | +$1.15M | ﹤0.01% | 1339 |
|
|
2023
Q1 | $461K | Buy |
139,314
+16,463
| +13% | +$54.5K | ﹤0.01% | 1807 |
|
|
2022
Q4 | $477K | Buy |
122,851
+48,655
| +66% | +$189K | ﹤0.01% | 1834 |
|
|
2022
Q3 | $180K | Buy |
+74,196
| New | +$180K | ﹤0.01% | 2055 |
|
|
2020
Q3 | – | Sell |
-29,215
| Closed | -$86K | – | 2167 |
|
|
2020
Q2 | $86K | Buy |
+29,215
| New | +$86K | ﹤0.01% | 2062 |
|